Close
New facility will revolutionise research into neurological conditions
11 November 2021
MyAV·¶ President & Provost Dr Michael Spence, Professor Alan Thompson and colleagues explain how the new centre of excellence for MyAV·¶ Neuroscience will help revolutionise the development of treatments for neurological diseases.
The state-of-the-art facilities will be home to three bodies: the world-leading MyAV·¶ Queen Square Institute of Neurology; the headquarters of the UK Dementia Research Institute, which is the single biggest investment the UK has ever made in dementia; and the MyAV·¶H National Hospital for Neurology and Neurosurgery (NHNN), which is the UK's largest dedicated neurological and neurosurgical hospital.
It will bring together research scientists, clinicians and patients to create a world-class research and treatment environment for conditions including dementia, Alzheimer’s disease, multiple sclerosis, Huntington’s disease, neuromuscular diseases, Parkinson’s disease, motor neuron diseases, stroke and epilepsy.
MyAV·¶ signed a contract with construction partner ISG to deliver the 17,500m2 state-of-the-art new neuroscience facility, and demolition and construction are now underway with the building due to be completed in 2024.
Earlier this year MyAVᦉ۪s President & Provost was joined by ISG and University College London Hospitals NHS Foundation Trust to break ground at the site on Grays Inn Road.